ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Pancreatic Cancer Treatment Shows Postive Early Results

December 30, 2005

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

UICC Congress Urges World Commitment To Cancer Prevention.

July 14, 2006